1-3 of 3
Paola Sinibaldi-Salimei
Close
Sort by
Journal Articles

A Distinctive Pattern of Different Gene Expression in Chronic Myelogenous Leukemia Patients

Carla Di Stefano, Marco Tafani, Bruna Pucci, Elisabetta Abruzzese, Margherita Trawiska, Manuela Indelicato, Margherita Trawiska, Paola Sinibaldi-Salimei, matteo Antonio Russo, Sergio Amadori, Gabriella Marfe
Journal: Blood
Blood (2008) 112 (11): 4231.
https://doi.org/10.1182/blood.V112.11.4231.4231
Published: 2008
Journal Articles

Pyrrolo[1,2- B ][1,2,5] benzodiazepines (PBTDs) Compounds Induce Apoptosis in Chronic Myeloid Leukaemia Cells from Patients at Onset, Imatinib and Second Generation TK Inhibitors (Dasatinib, Nilotinib) Resistant.

Elisabetta Abruzzese, MD, Gabriella Marfe’, PhD, Carla Di Stefano, MD, Malgorzata M. Trawinska, MD, Matteo A. Russo, MD, Romano Silvestri, PhD, Giovanni Del Poeta, MD, Giovanni Martinelli, MD, Simona Soverini, PhD, Paolo de Fabritiis, MD, Sergio Amadori, MD, Paola Sinibaldi Salimei, PhD
Journal: Blood
Blood (2006) 108 (11): 1385.
https://doi.org/10.1182/blood.V108.11.1385.1385
Published: 2006
Journal Articles

Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in Cell Lines and in 12 Chronic Myeloid Leukemia Patients at Onset and Imatinib-Resistant.

Carla Di Stefano, MD, Elisabetta Abruzzese, MD, Gabriella Marfe, BS, Romano Silvestri, Pharmacy, Gianfranco Catalano, MD, Malgorzata M. Trawinska, MD, Paola Sinibaldi-Salimei, MD, Sergio Amadori, MD
Journal: Blood
Blood (2004) 104 (11): 4692.
https://doi.org/10.1182/blood.V104.11.4692.4692
Published: 2004